2 Market-Beating Stocks With Major Catalysts on the Way
For those seeking stocks that have trounced the market over the past year, the biotech sector might be an excellent place to start. The SPDR S&P Biotech Index ETF, an industry benchmark, has climbed 34% over the trailing-12-month period, nearly three times the gains of the S&P 500.
Two drugmakers that have done particularly well for themselves are Vertex Pharmaceuticals (NASDAQ: VRTX) and Biogen (NASDAQ: BIIB). Moreover, both companies expect catalysts that could send their results even higher. Let's consider whether that makes either stock a buy.
Source Fool.com
Biogen Inc. Aktie
181,10 €
-0,47 %
Die Community zeigt großes Interesse an Biogen Inc. mit vielen Buy- und wenigen Sell-Einschätzungen.
Das Kursziel von 283 € für Biogen Inc. impliziert eine deutliche Steigerung um über 50% gegenüber 181.1 €.
